nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—HTR1A—stomach cancer	0.363	1	CbGaD
Prazosin—SLC22A3—Irinotecan—stomach cancer	0.106	0.27	CbGbCtD
Prazosin—ABCB1—Mitomycin—stomach cancer	0.0649	0.166	CbGbCtD
Prazosin—ABCG2—Irinotecan—stomach cancer	0.0462	0.118	CbGbCtD
Prazosin—ABCG2—Fluorouracil—stomach cancer	0.0443	0.113	CbGbCtD
Prazosin—ABCG2—Docetaxel—stomach cancer	0.0339	0.0865	CbGbCtD
Prazosin—ABCG2—Doxorubicin—stomach cancer	0.0252	0.0645	CbGbCtD
Prazosin—ABCG2—Methotrexate—stomach cancer	0.0244	0.0624	CbGbCtD
Prazosin—ABCB1—Irinotecan—stomach cancer	0.0167	0.0425	CbGbCtD
Prazosin—ABCB1—Docetaxel—stomach cancer	0.0122	0.0312	CbGbCtD
Prazosin—ABCB1—Doxorubicin—stomach cancer	0.0091	0.0232	CbGbCtD
Prazosin—ABCB1—Methotrexate—stomach cancer	0.00882	0.0225	CbGbCtD
Prazosin—ORM1—bile—stomach cancer	0.00695	0.18	CbGeAlD
Prazosin—MT3—endocrine gland—stomach cancer	0.00193	0.0501	CbGeAlD
Prazosin—ORM1—gall bladder—stomach cancer	0.00193	0.05	CbGeAlD
Prazosin—HTR1D—blood vessel—stomach cancer	0.00186	0.0483	CbGeAlD
Prazosin—MT3—lymph node—stomach cancer	0.00133	0.0346	CbGeAlD
Prazosin—ADRA1D—epithelium—stomach cancer	0.00121	0.0314	CbGeAlD
Prazosin—ORM1—hematopoietic system—stomach cancer	0.00109	0.0283	CbGeAlD
Prazosin—SLC22A2—digestive system—stomach cancer	0.000985	0.0255	CbGeAlD
Prazosin—SLC22A3—hematopoietic system—stomach cancer	0.000956	0.0248	CbGeAlD
Prazosin—SLC22A3—smooth muscle tissue—stomach cancer	0.000842	0.0218	CbGeAlD
Prazosin—HTR1A—hematopoietic system—stomach cancer	0.000826	0.0214	CbGeAlD
Prazosin—ADRA1D—endocrine gland—stomach cancer	0.000762	0.0198	CbGeAlD
Prazosin—ADRA1A—hematopoietic system—stomach cancer	0.000761	0.0198	CbGeAlD
Prazosin—KCNH2—hematopoietic system—stomach cancer	0.000735	0.0191	CbGeAlD
Prazosin—ORM1—bone marrow—stomach cancer	0.0007	0.0182	CbGeAlD
Prazosin—ADRA1A—epithelium—stomach cancer	0.000696	0.0181	CbGeAlD
Prazosin—ORM1—endocrine gland—stomach cancer	0.000627	0.0163	CbGeAlD
Prazosin—CYP1A1—hematopoietic system—stomach cancer	0.000621	0.0161	CbGeAlD
Prazosin—ABCB1—blood vessel—stomach cancer	0.000606	0.0157	CbGeAlD
Prazosin—ADRA2A—hematopoietic system—stomach cancer	0.000579	0.015	CbGeAlD
Prazosin—SLC22A1—endocrine gland—stomach cancer	0.000575	0.0149	CbGeAlD
Prazosin—CYP1A1—epithelium—stomach cancer	0.000568	0.0147	CbGeAlD
Prazosin—ORM1—liver—stomach cancer	0.000566	0.0147	CbGeAlD
Prazosin—SLC22A3—endocrine gland—stomach cancer	0.000549	0.0142	CbGeAlD
Prazosin—ADRA1A—lymphoid tissue—stomach cancer	0.000536	0.0139	CbGeAlD
Prazosin—SLC22A1—liver—stomach cancer	0.000518	0.0134	CbGeAlD
Prazosin—SLC22A3—liver—stomach cancer	0.000495	0.0128	CbGeAlD
Prazosin—HTR1A—endocrine gland—stomach cancer	0.000475	0.0123	CbGeAlD
Prazosin—KCNH2—bone marrow—stomach cancer	0.000471	0.0122	CbGeAlD
Prazosin—ADRA2A—pancreas—stomach cancer	0.000471	0.0122	CbGeAlD
Prazosin—ADRA1A—endocrine gland—stomach cancer	0.000438	0.0114	CbGeAlD
Prazosin—ORM1—lymph node—stomach cancer	0.000434	0.0113	CbGeAlD
Prazosin—CYP1A1—digestive system—stomach cancer	0.000432	0.0112	CbGeAlD
Prazosin—KCNH2—endocrine gland—stomach cancer	0.000423	0.011	CbGeAlD
Prazosin—ABCG2—bone marrow—stomach cancer	0.000419	0.0109	CbGeAlD
Prazosin—ADRA1A—liver—stomach cancer	0.000395	0.0102	CbGeAlD
Prazosin—Ill-defined disorder—Irinotecan—stomach cancer	0.000393	0.00406	CcSEcCtD
Prazosin—Abdominal discomfort—Capecitabine—stomach cancer	0.00039	0.00403	CcSEcCtD
Prazosin—Vision blurred—Fluorouracil—stomach cancer	0.000382	0.00395	CcSEcCtD
Prazosin—Malaise—Irinotecan—stomach cancer	0.000382	0.00395	CcSEcCtD
Prazosin—Vertigo—Irinotecan—stomach cancer	0.00038	0.00393	CcSEcCtD
Prazosin—SLC22A3—lymph node—stomach cancer	0.00038	0.00985	CbGeAlD
Prazosin—Syncope—Irinotecan—stomach cancer	0.000379	0.00393	CcSEcCtD
Prazosin—Loss of consciousness—Irinotecan—stomach cancer	0.000372	0.00385	CcSEcCtD
Prazosin—Eye pain—Epirubicin—stomach cancer	0.000363	0.00375	CcSEcCtD
Prazosin—CYP1A1—endocrine gland—stomach cancer	0.000357	0.00926	CbGeAlD
Prazosin—Discomfort—Irinotecan—stomach cancer	0.000356	0.00368	CcSEcCtD
Prazosin—Epistaxis—Docetaxel—stomach cancer	0.000353	0.00365	CcSEcCtD
Prazosin—Oedema—Irinotecan—stomach cancer	0.000345	0.00357	CcSEcCtD
Prazosin—Epistaxis—Capecitabine—stomach cancer	0.000342	0.00354	CcSEcCtD
Prazosin—Discomfort—Fluorouracil—stomach cancer	0.000341	0.00353	CcSEcCtD
Prazosin—Shock—Irinotecan—stomach cancer	0.00034	0.00352	CcSEcCtD
Prazosin—ABCG2—liver—stomach cancer	0.000339	0.00879	CbGeAlD
Prazosin—Eye pain—Doxorubicin—stomach cancer	0.000336	0.00347	CcSEcCtD
Prazosin—Hyperhidrosis—Irinotecan—stomach cancer	0.000334	0.00345	CcSEcCtD
Prazosin—ADRA2A—endocrine gland—stomach cancer	0.000333	0.00863	CbGeAlD
Prazosin—Bradycardia—Capecitabine—stomach cancer	0.000331	0.00343	CcSEcCtD
Prazosin—Oedema—Fluorouracil—stomach cancer	0.000331	0.00342	CcSEcCtD
Prazosin—Tachycardia—Fluorouracil—stomach cancer	0.000323	0.00334	CcSEcCtD
Prazosin—ABCB1—hematopoietic system—stomach cancer	0.000323	0.00837	CbGeAlD
Prazosin—CYP1A1—liver—stomach cancer	0.000322	0.00835	CbGeAlD
Prazosin—Insomnia—Irinotecan—stomach cancer	0.000312	0.00323	CcSEcCtD
Prazosin—Flushing—Docetaxel—stomach cancer	0.000312	0.00323	CcSEcCtD
Prazosin—Paraesthesia—Irinotecan—stomach cancer	0.00031	0.00321	CcSEcCtD
Prazosin—Dyspnoea—Irinotecan—stomach cancer	0.000308	0.00319	CcSEcCtD
Prazosin—Somnolence—Irinotecan—stomach cancer	0.000307	0.00318	CcSEcCtD
Prazosin—Tinnitus—Capecitabine—stomach cancer	0.000303	0.00314	CcSEcCtD
Prazosin—Flushing—Capecitabine—stomach cancer	0.000302	0.00312	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000301	0.00312	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—stomach cancer	0.000299	0.0031	CcSEcCtD
Prazosin—Insomnia—Fluorouracil—stomach cancer	0.000299	0.0031	CcSEcCtD
Prazosin—Fatigue—Irinotecan—stomach cancer	0.000298	0.00308	CcSEcCtD
Prazosin—Paraesthesia—Fluorouracil—stomach cancer	0.000297	0.00307	CcSEcCtD
Prazosin—Alopecia—Docetaxel—stomach cancer	0.000297	0.00307	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—stomach cancer	0.000297	0.00307	CcSEcCtD
Prazosin—Pain—Irinotecan—stomach cancer	0.000295	0.00306	CcSEcCtD
Prazosin—Constipation—Irinotecan—stomach cancer	0.000295	0.00306	CcSEcCtD
Prazosin—ABCB1—epithelium—stomach cancer	0.000295	0.00765	CbGeAlD
Prazosin—Dyspnoea—Fluorouracil—stomach cancer	0.000295	0.00305	CcSEcCtD
Prazosin—Somnolence—Fluorouracil—stomach cancer	0.000294	0.00304	CcSEcCtD
Prazosin—KCNH2—lymph node—stomach cancer	0.000292	0.00758	CbGeAlD
Prazosin—Abdominal discomfort—Methotrexate—stomach cancer	0.00029	0.003	CcSEcCtD
Prazosin—Alopecia—Capecitabine—stomach cancer	0.000287	0.00297	CcSEcCtD
Prazosin—Feeling abnormal—Irinotecan—stomach cancer	0.000285	0.00294	CcSEcCtD
Prazosin—Pain—Fluorouracil—stomach cancer	0.000283	0.00293	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—stomach cancer	0.000279	0.00288	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—stomach cancer	0.000278	0.00287	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000277	0.00286	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—stomach cancer	0.000276	0.00285	CcSEcCtD
Prazosin—Body temperature increased—Irinotecan—stomach cancer	0.000273	0.00282	CcSEcCtD
Prazosin—Feeling abnormal—Fluorouracil—stomach cancer	0.000273	0.00282	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—stomach cancer	0.00027	0.00279	CcSEcCtD
Prazosin—Vision blurred—Capecitabine—stomach cancer	0.000267	0.00276	CcSEcCtD
Prazosin—Ill-defined disorder—Capecitabine—stomach cancer	0.000263	0.00272	CcSEcCtD
Prazosin—Urticaria—Fluorouracil—stomach cancer	0.000263	0.00272	CcSEcCtD
Prazosin—ABCB1—pancreas—stomach cancer	0.000263	0.00681	CbGeAlD
Prazosin—Syncope—Docetaxel—stomach cancer	0.000262	0.00271	CcSEcCtD
Prazosin—Pollakiuria—Epirubicin—stomach cancer	0.000262	0.00271	CcSEcCtD
Prazosin—Body temperature increased—Fluorouracil—stomach cancer	0.000261	0.00271	CcSEcCtD
Prazosin—ABCG2—lymph node—stomach cancer	0.00026	0.00674	CbGeAlD
Prazosin—Palpitations—Docetaxel—stomach cancer	0.000258	0.00267	CcSEcCtD
Prazosin—Loss of consciousness—Docetaxel—stomach cancer	0.000257	0.00266	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—stomach cancer	0.000257	0.00266	CcSEcCtD
Prazosin—Malaise—Capecitabine—stomach cancer	0.000255	0.00264	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—stomach cancer	0.000255	0.00264	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—stomach cancer	0.000254	0.00263	CcSEcCtD
Prazosin—Vertigo—Capecitabine—stomach cancer	0.000254	0.00263	CcSEcCtD
Prazosin—Hypersensitivity—Irinotecan—stomach cancer	0.000254	0.00263	CcSEcCtD
Prazosin—Syncope—Capecitabine—stomach cancer	0.000254	0.00263	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—stomach cancer	0.000252	0.00261	CcSEcCtD
Prazosin—Palpitations—Capecitabine—stomach cancer	0.00025	0.00259	CcSEcCtD
Prazosin—Arthralgia—Docetaxel—stomach cancer	0.000249	0.00258	CcSEcCtD
Prazosin—Loss of consciousness—Capecitabine—stomach cancer	0.000249	0.00258	CcSEcCtD
Prazosin—Asthenia—Irinotecan—stomach cancer	0.000248	0.00256	CcSEcCtD
Prazosin—CYP1A1—lymph node—stomach cancer	0.000247	0.0064	CbGeAlD
Prazosin—Hypersensitivity—Fluorouracil—stomach cancer	0.000244	0.00252	CcSEcCtD
Prazosin—Dry mouth—Docetaxel—stomach cancer	0.000244	0.00252	CcSEcCtD
Prazosin—Pollakiuria—Doxorubicin—stomach cancer	0.000242	0.0025	CcSEcCtD
Prazosin—Arthralgia—Capecitabine—stomach cancer	0.000241	0.00249	CcSEcCtD
Prazosin—Oedema—Docetaxel—stomach cancer	0.000239	0.00247	CcSEcCtD
Prazosin—Discomfort—Capecitabine—stomach cancer	0.000238	0.00246	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—stomach cancer	0.000238	0.00246	CcSEcCtD
Prazosin—Diarrhoea—Irinotecan—stomach cancer	0.000236	0.00244	CcSEcCtD
Prazosin—Dry mouth—Capecitabine—stomach cancer	0.000236	0.00244	CcSEcCtD
Prazosin—Shock—Docetaxel—stomach cancer	0.000235	0.00243	CcSEcCtD
Prazosin—Pruritus—Fluorouracil—stomach cancer	0.000234	0.00242	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—stomach cancer	0.000234	0.00242	CcSEcCtD
Prazosin—Tachycardia—Docetaxel—stomach cancer	0.000233	0.00241	CcSEcCtD
Prazosin—Oedema—Capecitabine—stomach cancer	0.000231	0.00239	CcSEcCtD
Prazosin—Bradycardia—Epirubicin—stomach cancer	0.000231	0.00239	CcSEcCtD
Prazosin—ADRA2A—lymph node—stomach cancer	0.00023	0.00597	CbGeAlD
Prazosin—Dizziness—Irinotecan—stomach cancer	0.000228	0.00236	CcSEcCtD
Prazosin—Shock—Capecitabine—stomach cancer	0.000227	0.00235	CcSEcCtD
Prazosin—ABCB1—lymphoid tissue—stomach cancer	0.000227	0.00589	CbGeAlD
Prazosin—Diarrhoea—Fluorouracil—stomach cancer	0.000226	0.00234	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—stomach cancer	0.000226	0.00234	CcSEcCtD
Prazosin—Tachycardia—Capecitabine—stomach cancer	0.000226	0.00233	CcSEcCtD
Prazosin—ABCB1—digestive system—stomach cancer	0.000224	0.00582	CbGeAlD
Prazosin—Hyperhidrosis—Capecitabine—stomach cancer	0.000223	0.00231	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—stomach cancer	0.00022	0.00228	CcSEcCtD
Prazosin—Vomiting—Irinotecan—stomach cancer	0.00022	0.00227	CcSEcCtD
Prazosin—Dizziness—Fluorouracil—stomach cancer	0.000219	0.00226	CcSEcCtD
Prazosin—Rash—Irinotecan—stomach cancer	0.000218	0.00225	CcSEcCtD
Prazosin—Dermatitis—Irinotecan—stomach cancer	0.000218	0.00225	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000217	0.00225	CcSEcCtD
Prazosin—Headache—Irinotecan—stomach cancer	0.000216	0.00224	CcSEcCtD
Prazosin—Insomnia—Docetaxel—stomach cancer	0.000216	0.00223	CcSEcCtD
Prazosin—Paraesthesia—Docetaxel—stomach cancer	0.000214	0.00222	CcSEcCtD
Prazosin—Alopecia—Methotrexate—stomach cancer	0.000214	0.00221	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—stomach cancer	0.000213	0.00221	CcSEcCtD
Prazosin—Dyspnoea—Docetaxel—stomach cancer	0.000213	0.0022	CcSEcCtD
Prazosin—Somnolence—Docetaxel—stomach cancer	0.000212	0.0022	CcSEcCtD
Prazosin—Tinnitus—Epirubicin—stomach cancer	0.000211	0.00219	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000211	0.00218	CcSEcCtD
Prazosin—Flushing—Epirubicin—stomach cancer	0.00021	0.00218	CcSEcCtD
Prazosin—Vomiting—Fluorouracil—stomach cancer	0.00021	0.00218	CcSEcCtD
Prazosin—Insomnia—Capecitabine—stomach cancer	0.000209	0.00216	CcSEcCtD
Prazosin—Rash—Fluorouracil—stomach cancer	0.000209	0.00216	CcSEcCtD
Prazosin—Dermatitis—Fluorouracil—stomach cancer	0.000208	0.00216	CcSEcCtD
Prazosin—Paraesthesia—Capecitabine—stomach cancer	0.000208	0.00215	CcSEcCtD
Prazosin—Headache—Fluorouracil—stomach cancer	0.000207	0.00214	CcSEcCtD
Prazosin—ABCB1—bone marrow—stomach cancer	0.000207	0.00536	CbGeAlD
Prazosin—Dyspnoea—Capecitabine—stomach cancer	0.000206	0.00213	CcSEcCtD
Prazosin—Fatigue—Docetaxel—stomach cancer	0.000206	0.00213	CcSEcCtD
Prazosin—Nausea—Irinotecan—stomach cancer	0.000205	0.00212	CcSEcCtD
Prazosin—Constipation—Docetaxel—stomach cancer	0.000204	0.00211	CcSEcCtD
Prazosin—Pain—Docetaxel—stomach cancer	0.000204	0.00211	CcSEcCtD
Prazosin—Alopecia—Epirubicin—stomach cancer	0.0002	0.00207	CcSEcCtD
Prazosin—Fatigue—Capecitabine—stomach cancer	0.000199	0.00206	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—stomach cancer	0.000199	0.00206	CcSEcCtD
Prazosin—Pain—Capecitabine—stomach cancer	0.000198	0.00205	CcSEcCtD
Prazosin—Constipation—Capecitabine—stomach cancer	0.000198	0.00205	CcSEcCtD
Prazosin—Feeling abnormal—Docetaxel—stomach cancer	0.000197	0.00204	CcSEcCtD
Prazosin—Nausea—Fluorouracil—stomach cancer	0.000196	0.00203	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—stomach cancer	0.000196	0.00202	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—stomach cancer	0.000195	0.00202	CcSEcCtD
Prazosin—Flushing—Doxorubicin—stomach cancer	0.000195	0.00201	CcSEcCtD
Prazosin—Tension—Epirubicin—stomach cancer	0.000194	0.002	CcSEcCtD
Prazosin—Nervousness—Epirubicin—stomach cancer	0.000192	0.00198	CcSEcCtD
Prazosin—Feeling abnormal—Capecitabine—stomach cancer	0.00019	0.00197	CcSEcCtD
Prazosin—Malaise—Methotrexate—stomach cancer	0.00019	0.00197	CcSEcCtD
Prazosin—Vertigo—Methotrexate—stomach cancer	0.000189	0.00196	CcSEcCtD
Prazosin—Body temperature increased—Docetaxel—stomach cancer	0.000189	0.00195	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—stomach cancer	0.000186	0.00192	CcSEcCtD
Prazosin—ABCB1—endocrine gland—stomach cancer	0.000185	0.00481	CbGeAlD
Prazosin—Alopecia—Doxorubicin—stomach cancer	0.000185	0.00192	CcSEcCtD
Prazosin—Urticaria—Capecitabine—stomach cancer	0.000184	0.0019	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—stomach cancer	0.000183	0.00189	CcSEcCtD
Prazosin—Body temperature increased—Capecitabine—stomach cancer	0.000183	0.00189	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—stomach cancer	0.000179	0.00186	CcSEcCtD
Prazosin—Tension—Doxorubicin—stomach cancer	0.000179	0.00185	CcSEcCtD
Prazosin—Malaise—Epirubicin—stomach cancer	0.000178	0.00184	CcSEcCtD
Prazosin—Discomfort—Methotrexate—stomach cancer	0.000177	0.00183	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—stomach cancer	0.000177	0.00183	CcSEcCtD
Prazosin—Vertigo—Epirubicin—stomach cancer	0.000177	0.00183	CcSEcCtD
Prazosin—Syncope—Epirubicin—stomach cancer	0.000177	0.00183	CcSEcCtD
Prazosin—Hypersensitivity—Docetaxel—stomach cancer	0.000176	0.00182	CcSEcCtD
Prazosin—Palpitations—Epirubicin—stomach cancer	0.000174	0.0018	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—stomach cancer	0.000173	0.00179	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—stomach cancer	0.000172	0.00178	CcSEcCtD
Prazosin—Asthenia—Docetaxel—stomach cancer	0.000171	0.00177	CcSEcCtD
Prazosin—Hypersensitivity—Capecitabine—stomach cancer	0.00017	0.00176	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—stomach cancer	0.000169	0.00175	CcSEcCtD
Prazosin—Pruritus—Docetaxel—stomach cancer	0.000169	0.00175	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—stomach cancer	0.000168	0.00174	CcSEcCtD
Prazosin—ABCB1—liver—stomach cancer	0.000167	0.00434	CbGeAlD
Prazosin—Hyperhidrosis—Methotrexate—stomach cancer	0.000166	0.00172	CcSEcCtD
Prazosin—Discomfort—Epirubicin—stomach cancer	0.000166	0.00172	CcSEcCtD
Prazosin—Asthenia—Capecitabine—stomach cancer	0.000166	0.00172	CcSEcCtD
Prazosin—Malaise—Doxorubicin—stomach cancer	0.000165	0.0017	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—stomach cancer	0.000164	0.0017	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—stomach cancer	0.000164	0.0017	CcSEcCtD
Prazosin—Syncope—Doxorubicin—stomach cancer	0.000164	0.00169	CcSEcCtD
Prazosin—Pruritus—Capecitabine—stomach cancer	0.000164	0.00169	CcSEcCtD
Prazosin—Diarrhoea—Docetaxel—stomach cancer	0.000163	0.00169	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—stomach cancer	0.000161	0.00167	CcSEcCtD
Prazosin—Oedema—Epirubicin—stomach cancer	0.000161	0.00167	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—stomach cancer	0.00016	0.00166	CcSEcCtD
Prazosin—Shock—Epirubicin—stomach cancer	0.000158	0.00164	CcSEcCtD
Prazosin—Diarrhoea—Capecitabine—stomach cancer	0.000158	0.00164	CcSEcCtD
Prazosin—Dizziness—Docetaxel—stomach cancer	0.000158	0.00163	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—stomach cancer	0.000157	0.00163	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000157	0.00162	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—stomach cancer	0.000156	0.00161	CcSEcCtD
Prazosin—Insomnia—Methotrexate—stomach cancer	0.000156	0.00161	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—stomach cancer	0.000155	0.00161	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—stomach cancer	0.000154	0.0016	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—stomach cancer	0.000154	0.00159	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—stomach cancer	0.000153	0.00159	CcSEcCtD
Prazosin—Somnolence—Methotrexate—stomach cancer	0.000153	0.00158	CcSEcCtD
Prazosin—Dizziness—Capecitabine—stomach cancer	0.000153	0.00158	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—stomach cancer	0.000152	0.00157	CcSEcCtD
Prazosin—Vomiting—Docetaxel—stomach cancer	0.000152	0.00157	CcSEcCtD
Prazosin—Rash—Docetaxel—stomach cancer	0.000151	0.00156	CcSEcCtD
Prazosin—Dermatitis—Docetaxel—stomach cancer	0.00015	0.00156	CcSEcCtD
Prazosin—Headache—Docetaxel—stomach cancer	0.00015	0.00155	CcSEcCtD
Prazosin—Oedema—Doxorubicin—stomach cancer	0.000149	0.00154	CcSEcCtD
Prazosin—Fatigue—Methotrexate—stomach cancer	0.000148	0.00153	CcSEcCtD
Prazosin—Pain—Methotrexate—stomach cancer	0.000147	0.00152	CcSEcCtD
Prazosin—Vomiting—Capecitabine—stomach cancer	0.000147	0.00152	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000147	0.00152	CcSEcCtD
Prazosin—Shock—Doxorubicin—stomach cancer	0.000147	0.00152	CcSEcCtD
Prazosin—Rash—Capecitabine—stomach cancer	0.000146	0.00151	CcSEcCtD
Prazosin—Insomnia—Epirubicin—stomach cancer	0.000146	0.00151	CcSEcCtD
Prazosin—Dermatitis—Capecitabine—stomach cancer	0.000146	0.00151	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—stomach cancer	0.000145	0.0015	CcSEcCtD
Prazosin—Headache—Capecitabine—stomach cancer	0.000145	0.0015	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—stomach cancer	0.000145	0.0015	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000144	0.00149	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—stomach cancer	0.000144	0.00149	CcSEcCtD
Prazosin—Somnolence—Epirubicin—stomach cancer	0.000143	0.00148	CcSEcCtD
Prazosin—Nausea—Docetaxel—stomach cancer	0.000142	0.00147	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—stomach cancer	0.000142	0.00147	CcSEcCtD
Prazosin—Fatigue—Epirubicin—stomach cancer	0.000139	0.00144	CcSEcCtD
Prazosin—Constipation—Epirubicin—stomach cancer	0.000138	0.00142	CcSEcCtD
Prazosin—Pain—Epirubicin—stomach cancer	0.000138	0.00142	CcSEcCtD
Prazosin—Nausea—Capecitabine—stomach cancer	0.000137	0.00142	CcSEcCtD
Prazosin—Urticaria—Methotrexate—stomach cancer	0.000137	0.00141	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—stomach cancer	0.000136	0.00141	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000136	0.0014	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—stomach cancer	0.000135	0.00139	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—stomach cancer	0.000134	0.00138	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—stomach cancer	0.000133	0.00137	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—stomach cancer	0.000133	0.00137	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—stomach cancer	0.000132	0.00137	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—stomach cancer	0.000128	0.00133	CcSEcCtD
Prazosin—ABCB1—lymph node—stomach cancer	0.000128	0.00332	CbGeAlD
Prazosin—Urticaria—Epirubicin—stomach cancer	0.000128	0.00132	CcSEcCtD
Prazosin—Pain—Doxorubicin—stomach cancer	0.000127	0.00132	CcSEcCtD
Prazosin—Constipation—Doxorubicin—stomach cancer	0.000127	0.00132	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—stomach cancer	0.000127	0.00132	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—stomach cancer	0.000127	0.00131	CcSEcCtD
Prazosin—Asthenia—Methotrexate—stomach cancer	0.000123	0.00128	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—stomach cancer	0.000123	0.00127	CcSEcCtD
Prazosin—Pruritus—Methotrexate—stomach cancer	0.000122	0.00126	CcSEcCtD
Prazosin—Hypersensitivity—Epirubicin—stomach cancer	0.000119	0.00123	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—stomach cancer	0.000118	0.00122	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—stomach cancer	0.000118	0.00122	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—stomach cancer	0.000118	0.00122	CcSEcCtD
Prazosin—Asthenia—Epirubicin—stomach cancer	0.000116	0.0012	CcSEcCtD
Prazosin—Pruritus—Epirubicin—stomach cancer	0.000114	0.00118	CcSEcCtD
Prazosin—Dizziness—Methotrexate—stomach cancer	0.000114	0.00118	CcSEcCtD
Prazosin—Diarrhoea—Epirubicin—stomach cancer	0.00011	0.00114	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—stomach cancer	0.00011	0.00114	CcSEcCtD
Prazosin—Vomiting—Methotrexate—stomach cancer	0.000109	0.00113	CcSEcCtD
Prazosin—Rash—Methotrexate—stomach cancer	0.000108	0.00112	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—stomach cancer	0.000108	0.00112	CcSEcCtD
Prazosin—Headache—Methotrexate—stomach cancer	0.000108	0.00112	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—stomach cancer	0.000107	0.00111	CcSEcCtD
Prazosin—Dizziness—Epirubicin—stomach cancer	0.000106	0.0011	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—stomach cancer	0.000105	0.00109	CcSEcCtD
Prazosin—Vomiting—Epirubicin—stomach cancer	0.000102	0.00106	CcSEcCtD
Prazosin—Nausea—Methotrexate—stomach cancer	0.000102	0.00106	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—stomach cancer	0.000102	0.00105	CcSEcCtD
Prazosin—Rash—Epirubicin—stomach cancer	0.000102	0.00105	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—stomach cancer	0.000101	0.00105	CcSEcCtD
Prazosin—Headache—Epirubicin—stomach cancer	0.000101	0.00104	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—stomach cancer	9.85e-05	0.00102	CcSEcCtD
Prazosin—Nausea—Epirubicin—stomach cancer	9.56e-05	0.00099	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—stomach cancer	9.47e-05	0.00098	CcSEcCtD
Prazosin—Rash—Doxorubicin—stomach cancer	9.39e-05	0.000972	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—stomach cancer	9.38e-05	0.000971	CcSEcCtD
Prazosin—Headache—Doxorubicin—stomach cancer	9.33e-05	0.000966	CcSEcCtD
Prazosin—Nausea—Doxorubicin—stomach cancer	8.85e-05	0.000916	CcSEcCtD
Prazosin—HTR1D—Signaling Pathways—CXCL8—stomach cancer	5.94e-06	5.38e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—stomach cancer	5.9e-06	5.34e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	5.89e-06	5.33e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	5.85e-06	5.29e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.84e-06	5.29e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—MTHFR—stomach cancer	5.83e-06	5.27e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CDKN1B—stomach cancer	5.8e-06	5.25e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RHOA—stomach cancer	5.79e-06	5.24e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—stomach cancer	5.79e-06	5.24e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6R—stomach cancer	5.79e-06	5.24e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IRS2—stomach cancer	5.76e-06	5.22e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	5.76e-06	5.21e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTP1—stomach cancer	5.73e-06	5.19e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOS3—stomach cancer	5.73e-06	5.19e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APC—stomach cancer	5.73e-06	5.19e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	5.68e-06	5.14e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	5.68e-06	5.14e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HMOX1—stomach cancer	5.65e-06	5.12e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—stomach cancer	5.65e-06	5.11e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CAV1—stomach cancer	5.59e-06	5.06e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6R—stomach cancer	5.59e-06	5.06e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOA1—stomach cancer	5.57e-06	5.05e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—NOS3—stomach cancer	5.54e-06	5.01e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCND1—stomach cancer	5.53e-06	5.01e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—JUN—stomach cancer	5.52e-06	5e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—stomach cancer	5.49e-06	4.97e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	5.49e-06	4.97e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	5.48e-06	4.96e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—stomach cancer	5.48e-06	4.96e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	5.46e-06	4.94e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PPARG—stomach cancer	5.46e-06	4.94e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—stomach cancer	5.43e-06	4.92e-05	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	5.43e-06	4.91e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	5.42e-06	4.9e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CAV1—stomach cancer	5.38e-06	4.86e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—stomach cancer	5.37e-06	4.86e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	5.36e-06	4.85e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOA1—stomach cancer	5.36e-06	4.85e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	5.36e-06	4.85e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IRS2—stomach cancer	5.35e-06	4.85e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CDKN1A—stomach cancer	5.35e-06	4.84e-05	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PIK3CA—stomach cancer	5.33e-06	4.82e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TYMS—stomach cancer	5.33e-06	4.82e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6R—stomach cancer	5.32e-06	4.81e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	5.32e-06	4.81e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	5.3e-06	4.79e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTM1—stomach cancer	5.27e-06	4.77e-05	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	5.24e-06	4.74e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	5.23e-06	4.73e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RHOA—stomach cancer	5.23e-06	4.73e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK8—stomach cancer	5.22e-06	4.73e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	5.22e-06	4.73e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	5.22e-06	4.72e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CAV1—stomach cancer	5.19e-06	4.7e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOA1—stomach cancer	5.18e-06	4.69e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—KRAS—stomach cancer	5.18e-06	4.69e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOS3—stomach cancer	5.17e-06	4.68e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.14e-06	4.65e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APC—stomach cancer	5.09e-06	4.61e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	5.08e-06	4.6e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—stomach cancer	5.07e-06	4.58e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	5.05e-06	4.57e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RHOA—stomach cancer	5.05e-06	4.57e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOS3—stomach cancer	4.99e-06	4.52e-05	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	4.99e-06	4.52e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	4.98e-06	4.51e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	4.96e-06	4.49e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ERCC2—stomach cancer	4.95e-06	4.48e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	4.94e-06	4.47e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	4.93e-06	4.46e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	4.93e-06	4.46e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	4.92e-06	4.45e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—stomach cancer	4.91e-06	4.44e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	4.87e-06	4.41e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	4.84e-06	4.38e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—stomach cancer	4.83e-06	4.37e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—stomach cancer	4.82e-06	4.37e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RHOA—stomach cancer	4.81e-06	4.35e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—STAT3—stomach cancer	4.78e-06	4.32e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	4.76e-06	4.31e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOS3—stomach cancer	4.76e-06	4.3e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCND1—stomach cancer	4.74e-06	4.29e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APC—stomach cancer	4.73e-06	4.28e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6R—stomach cancer	4.73e-06	4.28e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—JUN—stomach cancer	4.73e-06	4.28e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPARG—stomach cancer	4.73e-06	4.28e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NOS3—stomach cancer	4.69e-06	4.25e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB2—stomach cancer	4.67e-06	4.23e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—MTHFR—stomach cancer	4.65e-06	4.21e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	4.64e-06	4.2e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	4.64e-06	4.2e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—stomach cancer	4.6e-06	4.16e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	4.59e-06	4.15e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	4.58e-06	4.15e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK3—stomach cancer	4.56e-06	4.13e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	4.56e-06	4.13e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	4.53e-06	4.1e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	4.53e-06	4.1e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	4.48e-06	4.06e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	4.47e-06	4.05e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	4.45e-06	4.03e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MYC—stomach cancer	4.44e-06	4.02e-05	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	4.43e-06	4.01e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL8—stomach cancer	4.43e-06	4.01e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	4.43e-06	4e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—stomach cancer	4.4e-06	3.98e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6R—stomach cancer	4.39e-06	3.97e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	4.38e-06	3.96e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—stomach cancer	4.36e-06	3.95e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK1—stomach cancer	4.34e-06	3.93e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—stomach cancer	4.34e-06	3.93e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	4.33e-06	3.92e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	4.31e-06	3.9e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	4.31e-06	3.9e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—stomach cancer	4.29e-06	3.89e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CAV1—stomach cancer	4.29e-06	3.89e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOA1—stomach cancer	4.28e-06	3.88e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCND1—stomach cancer	4.28e-06	3.87e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RHOA—stomach cancer	4.27e-06	3.86e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—JUN—stomach cancer	4.27e-06	3.86e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—stomach cancer	4.25e-06	3.85e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOS3—stomach cancer	4.22e-06	3.82e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	4.22e-06	3.82e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—stomach cancer	4.21e-06	3.81e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	4.19e-06	3.79e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—stomach cancer	4.15e-06	3.76e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	4.14e-06	3.74e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	4.13e-06	3.74e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCND1—stomach cancer	4.13e-06	3.74e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	4.12e-06	3.73e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—JUN—stomach cancer	4.12e-06	3.73e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	4.12e-06	3.73e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	4.11e-06	3.72e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KRAS—stomach cancer	4.1e-06	3.71e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—STAT3—stomach cancer	4.09e-06	3.7e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	4.07e-06	3.68e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NOS3—stomach cancer	4.06e-06	3.68e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	4.04e-06	3.65e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	4.02e-06	3.64e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—stomach cancer	4.01e-06	3.63e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—stomach cancer	4.01e-06	3.63e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3.99e-06	3.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RHOA—stomach cancer	3.97e-06	3.59e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	3.95e-06	3.58e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCND1—stomach cancer	3.93e-06	3.56e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOS3—stomach cancer	3.93e-06	3.55e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—JUN—stomach cancer	3.92e-06	3.55e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	3.91e-06	3.53e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK8—stomach cancer	3.9e-06	3.53e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—stomach cancer	3.82e-06	3.45e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	3.8e-06	3.44e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MYC—stomach cancer	3.8e-06	3.44e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARG—stomach cancer	3.77e-06	3.42e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	3.77e-06	3.41e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	3.75e-06	3.39e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	3.74e-06	3.38e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	3.73e-06	3.37e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	3.72e-06	3.37e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—stomach cancer	3.72e-06	3.36e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	3.72e-06	3.36e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—stomach cancer	3.72e-06	3.36e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	3.71e-06	3.36e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—STAT3—stomach cancer	3.69e-06	3.34e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	3.67e-06	3.32e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	3.66e-06	3.31e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—stomach cancer	3.65e-06	3.3e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—stomach cancer	3.6e-06	3.26e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—stomach cancer	3.56e-06	3.23e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STAT3—stomach cancer	3.56e-06	3.22e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	3.53e-06	3.19e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KRAS—stomach cancer	3.51e-06	3.18e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCND1—stomach cancer	3.49e-06	3.16e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—stomach cancer	3.49e-06	3.15e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—JUN—stomach cancer	3.48e-06	3.15e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	3.48e-06	3.15e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	3.46e-06	3.13e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MYC—stomach cancer	3.43e-06	3.1e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	3.43e-06	3.1e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK3—stomach cancer	3.4e-06	3.08e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	3.4e-06	3.08e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—stomach cancer	3.39e-06	3.07e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STAT3—stomach cancer	3.39e-06	3.07e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—stomach cancer	3.39e-06	3.07e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PIK3CA—stomach cancer	3.38e-06	3.06e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	3.38e-06	3.06e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	3.36e-06	3.04e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—stomach cancer	3.35e-06	3.04e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PIK3CA—stomach cancer	3.34e-06	3.03e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—stomach cancer	3.34e-06	3.02e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—stomach cancer	3.31e-06	3e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MYC—stomach cancer	3.31e-06	3e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	3.3e-06	2.98e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NOS3—stomach cancer	3.25e-06	2.94e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCND1—stomach cancer	3.24e-06	2.94e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK1—stomach cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—stomach cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JUN—stomach cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	3.22e-06	2.92e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KRAS—stomach cancer	3.17e-06	2.87e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MYC—stomach cancer	3.15e-06	2.85e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—stomach cancer	3.15e-06	2.85e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	3.14e-06	2.84e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—stomach cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PIK3CA—stomach cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	3.08e-06	2.79e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—stomach cancer	3.08e-06	2.79e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	3.06e-06	2.77e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KRAS—stomach cancer	3.06e-06	2.77e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STAT3—stomach cancer	3.01e-06	2.73e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.98e-06	2.7e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—stomach cancer	2.97e-06	2.69e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.91e-06	2.64e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	2.91e-06	2.63e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.88e-06	2.61e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—stomach cancer	2.86e-06	2.58e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.83e-06	2.56e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—stomach cancer	2.82e-06	2.55e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.81e-06	2.54e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.8e-06	2.53e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.8e-06	2.53e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.74e-06	2.48e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.74e-06	2.48e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—stomach cancer	2.72e-06	2.46e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—stomach cancer	2.69e-06	2.44e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	2.68e-06	2.42e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.68e-06	2.42e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.64e-06	2.39e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.6e-06	2.35e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.6e-06	2.35e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—stomach cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—stomach cancer	2.58e-06	2.33e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	2.55e-06	2.3e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—stomach cancer	2.55e-06	2.3e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—stomach cancer	2.49e-06	2.25e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—stomach cancer	2.48e-06	2.24e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KRAS—stomach cancer	2.4e-06	2.18e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.38e-06	2.15e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—stomach cancer	2.37e-06	2.14e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.3e-06	2.08e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.29e-06	2.07e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	2.21e-06	2e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.2e-06	1.99e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—stomach cancer	2.14e-06	1.93e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.11e-06	1.91e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—stomach cancer	2.04e-06	1.85e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.96e-06	1.77e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PIK3CA—stomach cancer	1.83e-06	1.65e-05	CbGpPWpGaD
